Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Tonix Pharmaceuticals Holding Corp. (TNXP : NSDQ)

• Company Description    Tonix Pharmaceuticals Holding Corp. is a specialty pharmaceutical company focused on developing new pharmaceutical products for CNS conditions. The Company develops therapies for disorders that include fibromyalgia syndrome and post-traumatic stress disorder. Its lead product candidates include TNX-102, for the management of fibromyalgia syndrome and TNX-105 to treat symptoms of post-traumatic stress disorder. Tonix Pharmaceuticals Holding Corp. is headquartered in New York. Number of Employees: 57

• Price / Volume Information    Yesterday's Closing Price: $17.00 Daily Weekly Monthly 20 Day Moving Average: 705,392 shares Shares Outstanding: 8.77 (millions) Market Capitalization: $149.02 (millions) Beta: 1.79 52 Week High: $72.00 52 Week Low: $6.76 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -19.77% -21.88% 12 Week -66.89% -68.27% Year To Date -48.45% -54.94%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 26 MAIN STREET SUITE 101 - CHATHAM,NJ 07928 USA ph: 862-799-8599 fax: 212-923-5700 investor.relations@tonixpharma.com http://www.tonixpharma.com

• General Corporate Information    Officers Seth Lederman - Chief Executive Officer; President and Director Bradley Saenger - Chief Financial Officer Richard Bagger - Director Margaret Smith Bell - Director David Grange - Director Peer Information Tonix Pharmaceuticals Holding Corp. (GSAC) Tonix Pharmaceuticals Holding Corp. (CASI) Tonix Pharmaceuticals Holding Corp. (ALCD.) Tonix Pharmaceuticals Holding Corp. (OMNN) Tonix Pharmaceuticals Holding Corp. (CGPI.) Tonix Pharmaceuticals Holding Corp. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: 890260839 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/11/25 Share - Related Items Shares Outstanding: 8.77 Most Recent Split Date: 2.00 (0.01:1) Beta: 1.79 Market Capitalization: $149.02 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-4.18 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-14.48 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.74 Price/Cash Flow: - Price / Sales: 15.16 EPS Growth vs. Year Ago Period: 99.80% vs. Previous Quarter: -35.92% Sales Growth vs. Year Ago Period: -9.51% vs. Previous Quarter: -17.74% ROE 09/30/25 - - 06/30/25 - -57.93 03/31/25 - -120.96 ROA 09/30/25 - - 06/30/25 - -51.04 03/31/25 - -101.28 Current Ratio 09/30/25 - - 06/30/25 - 7.53 03/31/25 - 12.31 Quick Ratio 09/30/25 - - 06/30/25 - 7.22 03/31/25 - 11.64 Operating Margin 09/30/25 - - 06/30/25 - -828.22 03/31/25 - -1,313.87 Net Margin 09/30/25 - - 06/30/25 - -828.22 03/31/25 - -1,313.87 Pre-Tax Margin 09/30/25 - - 06/30/25 - -828.22 03/31/25 - -1,313.87 Book Value 09/30/25 - - 06/30/25 - 22.83 03/31/25 - 28.03 Inventory Turnover 09/30/25 - - 06/30/25 - 0.91 03/31/25 - 0.83 Debt-to-Equity 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©